Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Short Candidates -- Ignore unavailable to you. Want to Upgrade?

To: keokalani'nui who wrote (751)	10/21/2005 12:17:22 PM
From: tuck	Read Replies (1) \| Respond to of 897

Sold at $14.95, bought at $14.40, could be worse. But stinky weird, I agree. I figured the opening gap would be just the beginning. Maybe TRMS has its own Plunge Protection Team in place now. I see I got whipsawed, it seems to be heading for the $13s again. But that spike over $15 made me wonder if I had missed an upgrade or something. There are indications that Fuzeon may yet allow TRMS to turn a profit, but that's next year, at best. Cheers, Tuck